NO306303B1 - Kondensert benzazepinderivat og farmasöytisk preparat derav - Google Patents
Kondensert benzazepinderivat og farmasöytisk preparat deravInfo
- Publication number
- NO306303B1 NO306303B1 NO960231A NO960231A NO306303B1 NO 306303 B1 NO306303 B1 NO 306303B1 NO 960231 A NO960231 A NO 960231A NO 960231 A NO960231 A NO 960231A NO 306303 B1 NO306303 B1 NO 306303B1
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparation
- benzazepine derivative
- condensed benzazepine
- condensed
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Output Control And Ontrol Of Special Type Engine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18043593 | 1993-07-21 | ||
PCT/JP1994/001183 WO1995003305A1 (fr) | 1993-07-21 | 1994-07-19 | Derive de benzazepine de fusion et composition pharmaceutique renfermant ce derive |
Publications (3)
Publication Number | Publication Date |
---|---|
NO960231D0 NO960231D0 (no) | 1996-01-19 |
NO960231L NO960231L (no) | 1996-03-21 |
NO306303B1 true NO306303B1 (no) | 1999-10-18 |
Family
ID=16083198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960231A NO306303B1 (no) | 1993-07-21 | 1996-01-19 | Kondensert benzazepinderivat og farmasöytisk preparat derav |
Country Status (18)
Country | Link |
---|---|
US (2) | US5723606A (de) |
EP (2) | EP1097920B1 (de) |
KR (1) | KR100304331B1 (de) |
CN (1) | CN1040210C (de) |
AT (2) | ATE277003T1 (de) |
AU (2) | AU683483B2 (de) |
CA (1) | CA2167673C (de) |
DE (2) | DE69432632T2 (de) |
ES (2) | ES2198418T3 (de) |
FI (1) | FI113178B (de) |
HU (1) | HUT74582A (de) |
NO (1) | NO306303B1 (de) |
NZ (1) | NZ268671A (de) |
PL (1) | PL177738B1 (de) |
RU (1) | RU2129123C1 (de) |
TW (1) | TW279163B (de) |
UA (1) | UA64690C2 (de) |
WO (1) | WO1995003305A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5693635A (en) * | 1993-07-29 | 1997-12-02 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
US5760031A (en) * | 1993-07-29 | 1998-06-02 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
AR002459A1 (es) * | 1995-01-17 | 1998-03-25 | American Cyanamid Co | Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion. |
WO1999038533A1 (fr) | 1998-01-28 | 1999-08-05 | Senju Pharmaceutical Co., Ltd. | Mesures prophylactiques ou remedes contre les troubles de la vision |
AR018818A1 (es) * | 1998-04-03 | 2001-12-12 | Yamano Masaki | Una composicion farmaceutica para la terapia de un edema. |
WO1999065525A1 (fr) * | 1998-06-19 | 1999-12-23 | Wakamoto Pharmaceutical Co., Ltd. | Agents permettant d'abaisser la tension oculaire et derives d'ester phosphorique |
US7015212B1 (en) | 1999-05-12 | 2006-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Thiazepine inhibitors of HIV-1 integrase |
US6765004B1 (en) * | 1999-06-17 | 2004-07-20 | Ortho-Mcneil Pharmaceutical, Inc. | Indoloazepines as vasopressin receptor antagonists |
US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
AU2001214778A1 (en) * | 2000-01-26 | 2001-08-07 | Warner Lambert Company | Method for preventing or treating postoperative ileus |
US20030103983A1 (en) * | 2002-05-09 | 2003-06-05 | Pressler Milton Lethan | Ace inhibitor-vasopressin antagonist combinations |
AU2001218083A1 (en) * | 2000-01-26 | 2001-08-07 | Warner Lambert Company | Ace inhibitor-vasopressin antagonist combinations |
US20030008860A1 (en) * | 2002-05-09 | 2003-01-09 | Bakker-Arkema Rebecca Guggemos | Treatment of congestive heart failure |
CA2357833C (en) | 2000-10-04 | 2005-11-15 | Warner-Lambert Company | Treatment of pulmonary hypertension using vasopressin antagonist |
AU779929B2 (en) * | 2000-10-04 | 2005-02-17 | Warner-Lambert Company | Treatment of pulmonary hypertension |
US7056910B2 (en) * | 2000-11-28 | 2006-06-06 | Astellas Pharma Inc. | 1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
US7691902B2 (en) * | 2005-12-28 | 2010-04-06 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
US7671221B2 (en) * | 2005-12-28 | 2010-03-02 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
US20080221084A1 (en) * | 2006-10-30 | 2008-09-11 | Otsuka Pharmaceutical Co., Ltd. | Method for reducing infarction using vasopressin antagonist compounds, and compositions and combinations therefor |
US20090069295A1 (en) * | 2007-09-09 | 2009-03-12 | Protia, Llc | Deuterium-enriched conivaptan |
CA2711644A1 (en) * | 2008-01-07 | 2009-07-16 | Synta Pharmaceuticals Corp. | Compounds for inflammation and immune-related uses |
WO2009102761A1 (en) * | 2008-02-12 | 2009-08-20 | Bristol-Myers Squibb Company | 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors |
US20110086834A1 (en) * | 2008-06-26 | 2011-04-14 | Amgen Inc. | Alkynyl alcohols as kinase inhibitors |
EP2495236A4 (de) * | 2009-10-26 | 2013-03-27 | Otsuka Pharma Co Ltd | Benzazepinverbindung |
US20150238502A1 (en) | 2012-10-18 | 2015-08-27 | University Of South Florida | Compositions and Methods for Treating Stroke |
CN103497195B (zh) * | 2013-10-21 | 2016-01-27 | 北京科莱博医药开发有限责任公司 | 盐酸考尼伐坦新晶型及其制备方法 |
CN105310978A (zh) * | 2014-08-04 | 2016-02-10 | 李峰 | 一种含有活性成分盐酸考尼伐坦的药物组合物及其制剂 |
CN105884778A (zh) * | 2014-09-24 | 2016-08-24 | 李峰 | 一种化合物和制备方法 |
CN105153168A (zh) * | 2015-09-29 | 2015-12-16 | 上海天慈国际药业有限公司 | N-[4-(2-甲基-4,5-二氢-3H-咪唑并[4,5-d][1]苯并氮杂卓-6-甲酰基)苯基]-2-苯基苯甲酰胺盐酸盐的制备方法 |
CN106317060B (zh) * | 2016-08-22 | 2019-02-15 | 山东罗欣药业集团恒欣药业有限公司 | 一种盐酸考尼伐坦的制备方法 |
US11498903B2 (en) | 2017-08-17 | 2022-11-15 | Bristol-Myers Squibb Company | 2-(1,1′-biphenyl)-1H-benzodimidazole derivatives and related compounds as apelin and APJ agonists for treating cardiovascular diseases |
HU231206B1 (hu) | 2017-12-15 | 2021-10-28 | Richter Gedeon Nyrt. | Triazolobenzazepinek |
TW201938171A (zh) | 2017-12-15 | 2019-10-01 | 匈牙利商羅特格登公司 | 作為血管升壓素V1a受體拮抗劑之三環化合物 |
EP4253367A1 (de) * | 2020-11-26 | 2023-10-04 | Shanghai Jemincare Pharmaceuticals Co., Ltd. | Neuartiges benzazepinspiroderivat |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011628A (en) * | 1988-06-15 | 1991-04-30 | Givaudan Corporation | N,N'-diarylbenzamidines useful as ultraviolet light absorbers |
DE68902874T2 (de) * | 1988-06-15 | 1993-04-08 | Givaudan & Cie Sa | Benzamidine, verwendbar als uv-licht-absorptionsmittel. |
US5225402A (en) * | 1989-02-10 | 1993-07-06 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
JP2905909B2 (ja) * | 1991-04-19 | 1999-06-14 | 大塚製薬株式会社 | バソプレシン拮抗剤 |
US5258510A (en) * | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
DE122009000062I2 (de) * | 1989-10-20 | 2011-01-13 | Otsuka Pharma Co Ltd | Benzoheterozyklische verbindungen |
JPH03255077A (ja) * | 1990-03-01 | 1991-11-13 | Taiji Nakayama | ピリミジン誘導体およびそれを有効成分とする血小板凝集阻止剤 |
CA2066104C (en) * | 1991-04-19 | 2003-05-27 | Hidenori Ogawa | Benzazepine derivatives as vasopressin antagonists |
US5512563A (en) * | 1993-07-29 | 1996-04-30 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
JP3255077B2 (ja) * | 1997-04-23 | 2002-02-12 | 日本電気株式会社 | 電話機 |
-
1994
- 1994-07-19 EP EP00204704A patent/EP1097920B1/de not_active Expired - Lifetime
- 1994-07-19 PL PL94312654A patent/PL177738B1/pl not_active IP Right Cessation
- 1994-07-19 ES ES94921117T patent/ES2198418T3/es not_active Expired - Lifetime
- 1994-07-19 KR KR1019960700265A patent/KR100304331B1/ko not_active IP Right Cessation
- 1994-07-19 DE DE69432632T patent/DE69432632T2/de not_active Expired - Lifetime
- 1994-07-19 NZ NZ268671A patent/NZ268671A/en not_active IP Right Cessation
- 1994-07-19 AT AT00204704T patent/ATE277003T1/de not_active IP Right Cessation
- 1994-07-19 ES ES00204704T patent/ES2228405T3/es not_active Expired - Lifetime
- 1994-07-19 EP EP94921117A patent/EP0709386B1/de not_active Expired - Lifetime
- 1994-07-19 DE DE69434032T patent/DE69434032T2/de not_active Expired - Lifetime
- 1994-07-19 AT AT94921117T patent/ATE239726T1/de not_active IP Right Cessation
- 1994-07-19 HU HU9600102A patent/HUT74582A/hu unknown
- 1994-07-19 RU RU96105390/04A patent/RU2129123C1/ru not_active IP Right Cessation
- 1994-07-19 AU AU71957/94A patent/AU683483B2/en not_active Ceased
- 1994-07-19 CN CN94192831A patent/CN1040210C/zh not_active Expired - Fee Related
- 1994-07-19 UA UA96010145A patent/UA64690C2/uk unknown
- 1994-07-19 US US08/586,686 patent/US5723606A/en not_active Expired - Lifetime
- 1994-07-19 CA CA002167673A patent/CA2167673C/en not_active Expired - Lifetime
- 1994-07-19 WO PCT/JP1994/001183 patent/WO1995003305A1/ja active IP Right Grant
- 1994-07-20 TW TW083106656A patent/TW279163B/zh not_active IP Right Cessation
-
1996
- 1996-01-19 FI FI960260A patent/FI113178B/fi active
- 1996-01-19 NO NO960231A patent/NO306303B1/no not_active IP Right Cessation
-
1997
- 1997-10-02 AU AU39906/97A patent/AU3990697A/en not_active Abandoned
- 1997-11-18 US US08/972,271 patent/US5856564A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO960231L (no) | Kondensert benzazepinderivat og farmasöytisk preparat derav | |
NO302366B1 (no) | 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat | |
NO940789L (no) | Quinolinkarboksylsyrederivater, deres fremstilling og anvendelse | |
IS6348A (is) | (1a,3a,5a)(3-amínómetýl bísýkló[3.2.0]hept-3-ýl)-ediksýra, lyfjasamsetningar og notkun efnasambandsins til framleiðslu á lyfjum | |
NZ234327A (en) | Quinazoline derivatives and pharmaceutical compositions | |
FI944217A (fi) | Substituoidut pipekoliinihappojohdannaiset HIV-proteaasin estäjinä | |
KR950700304A (ko) | 5ht4-수용체 길항질로서 축합 인돌 유도체(condensed indole derivatives as 5ht4-receptor antagonists) | |
DE69021618T2 (de) | Antagonisten von exzitatorischen Aminosäuren. | |
DE69734321D1 (de) | Non-peptidische vasopressin via antagonisten | |
KR950702832A (ko) | 아미노산 유도체(amino acid derivative) | |
NO921840D0 (no) | Substituerte karboksylsyrederivater | |
MX9204342A (es) | Indoles. | |
ES2111871T3 (es) | Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
FI941149A0 (fi) | 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia | |
MA23133A1 (fr) | Derives d'acide d'acyloxyhexanoique . | |
NO923266L (no) | Heksahydrobenzo(f)quinolinoner | |
NO952713D0 (no) | Fremgangsmåte for fremstilling av substituerte indolonderivater | |
KR950702115A (ko) | 디히드로피리딘 유도체의 신규 의약 용도(novel medicinal use of dihydropyridine derivative) | |
NO912167L (no) | Fremgangsmaate for fremstilling av ftalsyreanhydrid-derivater. | |
ES2080445T3 (es) | Derivados de ursano, su preparacion y formulaciones farmaceuticas de los mismos. | |
CA2453123A1 (en) | Intermediate for condensed benzazepine derivatives | |
DE633242T1 (de) | Derivate der Heptansäure. | |
TH33723A (de) | ||
NO932047D0 (no) | Fremgangsmaate ved fremstilling av folinsyrederivater | |
TH15282A (th) | " อนุพันธ์ควิโนโลน และแนพธิริโดนคาร์บอกซิลิแอซิด " |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |